DK1992696T3 - Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD). - Google Patents

Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD).

Info

Publication number
DK1992696T3
DK1992696T3 DK08154913.1T DK08154913T DK1992696T3 DK 1992696 T3 DK1992696 T3 DK 1992696T3 DK 08154913 T DK08154913 T DK 08154913T DK 1992696 T3 DK1992696 T3 DK 1992696T3
Authority
DK
Denmark
Prior art keywords
pwd
mammary gland
sequences associated
gland disease
circovirus sequences
Prior art date
Application number
DK08154913.1T
Other languages
English (en)
Inventor
André Jestin
Emmanuel Albina
Cann Pierre Le
Philippe Blanchard
Evelyne Hutet
Claire Arnaud
Catherine Truong
Dominique Mahe
Roland Cariolet
Fran Ois Madec
Original Assignee
Zoetis W Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to FR9715396A priority Critical patent/FR2772047B1/fr
Application filed by Zoetis W Llc filed Critical Zoetis W Llc
Priority to EP98958957A priority patent/EP1036180B2/fr
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1992696(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application granted granted Critical
Publication of DK1992696T3 publication Critical patent/DK1992696T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/10011Circoviridae
    • C12N2750/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/10011Circoviridae
    • C12N2750/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/10011Circoviridae
    • C12N2750/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/10011Circoviridae
    • C12N2750/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/10011Circoviridae
    • C12N2750/10061Methods of inactivation or attenuation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
DK08154913.1T 1997-12-05 1998-12-04 Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD). DK1992696T3 (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9715396A FR2772047B1 (fr) 1997-12-05 1997-12-05 Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP98958957A EP1036180B2 (fr) 1997-12-05 1998-12-04 COMPOSITION VACCINALE PREPAREE A PARTIR DE SEQUENCES DE CIRCOVIRUS DE TYPE B ASSOCIE A LA MALADIE DE L'AMAIGRISSEMENT DU PORCELET (map)

Publications (1)

Publication Number Publication Date
DK1992696T3 true DK1992696T3 (da) 2014-05-19

Family

ID=9514225

Family Applications (5)

Application Number Title Priority Date Filing Date
DK10184556.8T DK2316925T3 (da) 1997-12-05 1998-12-04 Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)
DK98958957.7T DK1036180T4 (da) 1997-12-05 1998-12-04 Vaccine på grundlag af sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD)
DK08154913.1T DK1992696T3 (da) 1997-12-05 1998-12-04 Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD).
DK08154912.3T DK2000535T3 (da) 1997-12-05 1998-12-04 Sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD).
DK10184626.9T DK2330188T3 (da) 1997-12-05 1998-12-04 Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK10184556.8T DK2316925T3 (da) 1997-12-05 1998-12-04 Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)
DK98958957.7T DK1036180T4 (da) 1997-12-05 1998-12-04 Vaccine på grundlag af sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD)

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK08154912.3T DK2000535T3 (da) 1997-12-05 1998-12-04 Sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD).
DK10184626.9T DK2330188T3 (da) 1997-12-05 1998-12-04 Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)

Country Status (14)

Country Link
US (43) US6703023B1 (da)
EP (6) EP2330188B1 (da)
AT (1) AT412664T (da)
AU (1) AU1491699A (da)
BE (2) BE2014C050I2 (da)
CY (4) CY1115405T1 (da)
DE (1) DE69840174D1 (da)
DK (5) DK2316925T3 (da)
ES (5) ES2548145T3 (da)
FR (1) FR2772047B1 (da)
HK (5) HK1158254A1 (da)
LU (2) LU92523I2 (da)
PT (5) PT1992696E (da)
WO (1) WO1999029871A2 (da)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6368601B1 (en) * 1997-10-03 2002-04-09 Merial Porcine circovirus vaccine and diagnostics reagents
AU2002302120B2 (en) * 1997-10-03 2006-01-19 Merial Porcine circoviruses, vaccines and diagnostic reagents
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
AU2003248395B2 (en) * 1997-10-03 2006-03-16 Merial Porcine CircoViruses, vaccines and diagnostic reagents
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999029717A2 (en) * 1997-12-11 1999-06-17 University Of Saskatchewan Postweaning multisystemic wasting syndrome virus from pigs
EP1816200B1 (en) * 1997-12-11 2016-03-09 Merial Postweaning multisystemic wasting syndrome virus for pigs
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
WO2001061024A2 (en) 2000-02-16 2001-08-23 Large Scale Biology Corporation Rolling circle replicon expression vectors
US6794163B2 (en) 2001-03-27 2004-09-21 University Of Saskatchewan Methods to culture circovirus
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
AU2011253941B2 (en) * 2004-12-30 2015-01-29 Boehringer Ingelheim Animal Health USA Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
PT2460817T (pt) 2004-12-30 2017-07-03 Boehringer Ingelheim Vetmedica Inc Composições imunogénicas de pcv2 e métodos de produção de tais composições
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006132598A1 (en) * 2005-06-07 2006-12-14 Temasek Life Sciences Laboratory Limited Porcine circovirus type 2 vaccines
UA95458C2 (ru) * 2005-09-09 2011-08-10 Интервет Интернешонал Б.В. Вакцина против pcv-2 у mda-положительных поросят
PT2371385E (pt) 2005-12-29 2015-11-27 Boehringer Ingelheim Vetmed Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
CN103536914B (zh) 2005-12-29 2015-11-11 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
EP2099927A4 (en) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
CN107412761A (zh) * 2006-12-15 2017-12-01 贝林格尔.英格海姆维特梅迪卡有限公司 以pcv2抗原治疗猪
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
AU2007353480B2 (en) * 2007-05-11 2013-09-19 Temasek Life Sciences Laboratory Limited Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
UA99495C2 (ru) * 2007-12-21 2012-08-27 Вайет Ллк Изольованный цирковирус свиней, композиции и способы для иммунизации свиней против цирковируса свиней
WO2009088950A2 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
BRPI0907438A2 (pt) 2008-01-23 2015-08-04 Boehringer Ingelheim Vetmed Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
CA2775277A1 (en) * 2009-10-16 2011-04-21 Pfizer Inc. Infectious clones of torque teno virus
KR20130126755A (ko) * 2008-10-16 2013-11-20 화이자 인코포레이티드 토크 테노 바이러스(ttv) 분리물 및 조성물
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
US20100150959A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. PCV 2-Based Methods and Compositions for the Treatment of Pigs
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
MX2012003972A (es) 2009-10-02 2012-05-08 Pionner Hi Bred International Inc Regulacion a la baja de acc sintasa para mejorar el rendimiento de las plantas.
WO2011048215A1 (en) * 2009-10-22 2011-04-28 Universität Leipzig Detection of a circovirus in calves suffering from bovine neonatal pancytopenia
WO2011091389A2 (en) * 2010-01-25 2011-07-28 Blood Systems, Inc. Cyclovirus and method of use
KR20110090711A (ko) * 2010-02-04 2011-08-10 녹십자수의약품(주) 신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI508974B (zh) 2010-12-22 2015-11-21 Sbc Virbac Ltd 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
EP2794643A1 (en) 2011-04-29 2014-10-29 Pioneer Hi-Bred International Inc. Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
HU1100470A2 (en) 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
EP2564869A1 (en) 2011-09-02 2013-03-06 Ceva Sante Animale Synthetic capsid proteins and uses thereof
TWI473813B (zh) 2011-12-06 2015-02-21 Sbc Virbac Ltd 豬第二型環狀病毒次單位疫苗
CN105026419A (zh) * 2013-03-01 2015-11-04 勃林格殷格翰动物保健公司 疫苗组合物定量
KR20140111541A (ko) * 2013-03-11 2014-09-19 한국생명공학연구원 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
EP2789346A1 (en) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
WO2015048115A1 (en) 2013-09-25 2015-04-02 Zoetis Llc Pcv2b divergent vaccine composition and methods of use
CA2924228A1 (en) 2013-10-02 2015-04-09 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 protein variant and virus like particles composed thereof
EP3034609A1 (en) 2014-12-19 2016-06-22 Ceva Sante Animale Recombinant swinepox virus and vaccines
WO2019032830A1 (en) 2017-08-09 2019-02-14 Dreamwell, Ltd. Adjustable foundation
EP3254692A1 (en) 2016-06-10 2017-12-13 Ceva Sante Animale Multivalent recombinant spv
WO2019110822A1 (en) 2017-12-08 2019-06-13 Ceva Sante Animale Recombinant swinepox virus and vaccines
WO2019191005A1 (en) 2018-03-26 2019-10-03 Boehringer Ingelheim Animal Health USA Inc. Method of producing an immunogenic composition
WO2019238611A1 (en) 2018-06-11 2019-12-19 Ceva Sante Animale Vaccination against porcine circoviruses

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US69750A (en) * 1867-10-15 Henry bean
US69233A (en) * 1867-09-24 Joseph r
FR2422956B1 (da) 1978-04-13 1980-11-28 Pasteur Institut
FR2464269B1 (fr) 1979-08-30 1986-04-18 Anvar Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr) 1981-12-23 1986-04-11 Pasteur Institut Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5550289A (en) 1985-01-07 1996-08-27 Syntex (U.S.A.) Inc. N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
US5106733A (en) 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
SU1538305A1 (ru) 1987-07-21 1994-12-15 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5069901A (en) 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
DE69027112D1 (de) 1989-01-23 1996-06-27 Auspharm Int Ltd Impfstoffzusammensetzung
US5811103A (en) 1989-03-19 1998-09-22 Akzo Nobel N.V. Hog cholera virus vaccine and diagnostic
EP1026253B2 (en) 1989-03-21 2012-12-19 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU657907B2 (en) 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
AU720640B2 (en) 1995-06-07 2000-06-08 Leadd B.V. Neutralizing conformational epitopes of chicken anemia virus
WO1992005255A1 (en) 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes
GB9023111D0 (en) * 1990-10-24 1990-12-05 Wellcome Found Expression system
ES2150419T3 (es) 1990-11-01 2000-12-01 Univ Iowa State Res Found Inc Procedimiento de atenuacion bacteriana y vacuna.
US5580557A (en) * 1991-10-09 1996-12-03 Iowa State University Research Foundation, Inc. Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
AU672359B2 (en) 1991-03-07 1996-10-03 Virogenetics Corporation Genetically engineered vaccine strain
ES2026827A6 (es) 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
US5382425A (en) 1992-01-13 1995-01-17 Syntro Corporation Recombinant swinepox virus
US6033904A (en) 1992-01-13 2000-03-07 Syntro Corporation Recombinant swinepox virus
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
MX9304089A (es) 1992-07-08 1994-01-31 Schering Corp Uso de gm-csf como una vacuna adyuvante.
JP3149116B2 (ja) * 1992-10-28 2001-03-26 シンエツ バイオ インコーポレイテッド ヒトパルボウイルスのエピトープ関連ペプチド
AT275191T (de) * 1992-11-09 2004-09-15 Zonagen Inc Methoden für die immunoempfängnisverhütung
JP3710095B2 (ja) 1993-02-08 2005-10-26 アイオワ・ステイト・ユニバーシテイ・リサーチ・フアウンデーシヨン・インコーポレーテツド ブタ生殖及び呼吸症候群ウイルスの増殖方法並びにワクチンにおけるその使用
IL108915D0 (en) 1993-03-18 1994-06-24 Merck & Co Inc Polynucleotide vaccine against influenza virus
EP0698245A1 (en) 1993-05-14 1996-02-28 Mds Health Group Limited Electronic worksheet system for microbiology testing and reporting
JPH09500013A (ja) 1993-06-01 1997-01-07 ライフ・テクノロジーズ・インコーポレイテッド カチオン性脂質による遺伝子免疫
CA2164088C (en) 1993-06-07 2005-06-14 Gary J. Nabel Plasmids suitable for gene therapy
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
FR2711670B1 (fr) 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
GB2285766B (en) 1994-01-21 1997-07-23 Ecc Int Ltd Ceramic casting composition
KR0121105B1 (ko) * 1994-02-04 1997-11-10 문정환 선입선출메모리 버스장치
WO1995024929A2 (en) 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system
AU694519B2 (en) 1994-04-29 1998-07-23 Immuno Aktiengesellschaft Recombinant poxviruses with foreign polynucleotides in essential regions
EP1844791A1 (en) 1994-05-10 2007-10-17 Wyeth a Corporation of the State of Delaware Improved modified live BRSV vaccine
DK53595A (da) 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
US5719131A (en) 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
WO1996034109A1 (en) 1995-04-25 1996-10-31 Vical Incorporated Single-vial formulations of dna/lipid complexes
US5681658A (en) * 1995-05-30 1997-10-28 Aluminum Company Of America Gelation-resistant alumina
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5705385A (en) 1995-06-07 1998-01-06 Inex Pharmaceuticals Corporation Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6019980A (en) 1995-06-07 2000-02-01 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines
US5795872A (en) 1995-09-19 1998-08-18 Pharmadigm, Inc. DNA construct for immunization
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
EP0835930B1 (en) * 1996-10-09 2001-01-31 Akzo Nobel N.V. European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
WO1998040499A1 (en) 1997-03-10 1998-09-17 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purposes
US6004777A (en) 1997-03-12 1999-12-21 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US5990091A (en) 1997-03-12 1999-11-23 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
US20030215445A1 (en) * 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6043232A (en) 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
FR2769322B1 (fr) 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2769321B1 (fr) 1997-10-03 2001-10-26 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6143334A (en) * 1997-10-03 2000-11-07 Sargento Foods Inc. Pasta filata method for manufacturing Swiss-type cheeses
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US6368601B1 (en) * 1997-10-03 2002-04-09 Merial Porcine circovirus vaccine and diagnostics reagents
US6165493A (en) 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7258865B2 (en) 1997-12-05 2007-08-21 Wyeth Circovirus sequences associated with piglet weight loss disease (PWD)
WO1999029717A2 (en) * 1997-12-11 1999-06-17 University Of Saskatchewan Postweaning multisystemic wasting syndrome virus from pigs
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6294176B1 (en) 1998-07-10 2001-09-25 Schering-Plough Veterinary Corp. Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
WO2000024428A2 (en) 1998-10-23 2000-05-04 Heska Corporation Cationic lipid-mediated enhancement of nucleic acid immunization of cats
US6143333A (en) 1998-11-13 2000-11-07 Purina Mills, Inc. Method of preparing a packaged fish attractant block
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6139179A (en) 1999-09-03 2000-10-31 Davis-Standard Corporation Extruder screw having multi-channeled barrier section
US6179461B1 (en) 1999-09-03 2001-01-30 Davis-Standard Corporation Extruder screw
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921147D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
WO2001017556A1 (en) 1999-09-07 2001-03-15 Shionogi & Co., Ltd. Vaccine preparations for mucosal administration
US6660727B1 (en) * 1999-11-10 2003-12-09 Rodenstock Gmbh Photochromic heterocyclically anellated indenochromene compounds
US6366601B1 (en) * 1999-11-17 2002-04-02 Motorola, Inc. Variable rate spread spectrum communication method and apparatus
JP3363419B2 (ja) * 1999-12-24 2003-01-08 住友ゴム工業株式会社 重荷重用ラジアルタイヤ
US7233407B1 (en) * 2000-02-02 2007-06-19 Xerox Corporation Document production system for capturing web page content
EP1290016A2 (en) 2000-06-15 2003-03-12 Purdue Research Foundation Vaccine for congenital tremors in pigs
JP4768106B2 (ja) 2000-07-31 2011-09-07 スリーエム イノベイティブ プロパティズ カンパニー 接着剤組成物及び熱剥離容易な接着構造
DE10044648A1 (de) * 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
DE10044646A1 (de) 2000-09-08 2002-04-04 Horsch Maschinen Gmbh Spritzgestängeführung
DE10051562A1 (de) * 2000-10-18 2002-04-25 Emitec Emissionstechnologie Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen
US6572081B2 (en) * 2000-12-27 2003-06-03 Nkf Kabel B.V. Installation of guide tubes in a protective duct
US6794163B2 (en) * 2001-03-27 2004-09-21 University Of Saskatchewan Methods to culture circovirus
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US20030215455A1 (en) * 2002-05-14 2003-11-20 Bailey Reynolds Vaccine stabilizer and method of use
AU2002347147A1 (en) * 2002-11-28 2004-06-18 Research In Motion Limited Multiple-band antenna with patch and slot structures
US7288529B2 (en) * 2003-04-24 2007-10-30 New York University ALK protein tyrosine kinase, cells and methods embodying and using same
AT442163T (de) * 2003-07-25 2009-09-15 Boehringer Ingelheim Vetmed Lawsonia intracellularis europäischen ursprungs und vakzine, diagnostika und anwendungsverfahren dafür
US20050279889A1 (en) 2004-06-08 2005-12-22 Safe Flight Instrument Corporation Variable wing spacecraft
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
WO2006074986A2 (en) * 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Prrs vaccines
KR101369656B1 (ko) * 2005-04-13 2014-03-04 메리얼 리미티드 돼지 써코바이러스 제조 방법 및 제조 모니터링을 위한검정법
PT2371385E (pt) * 2005-12-29 2015-11-27 Boehringer Ingelheim Vetmed Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
US8377070B2 (en) * 2007-05-17 2013-02-19 Michael T. Gauthier Compressor distractor tool
US8214576B2 (en) 2009-03-03 2012-07-03 Vmware, Inc. Zero copy transport for target based storage virtual appliances

Also Published As

Publication number Publication date
US9700613B2 (en) 2017-07-11
US7951907B2 (en) 2011-05-31
EP1992696A1 (fr) 2008-11-19
DK2316925T3 (da) 2015-10-12
US20040161410A1 (en) 2004-08-19
US7740865B2 (en) 2010-06-22
LU92524I2 (en) 2014-10-20
US20100189736A1 (en) 2010-07-29
US20050008651A1 (en) 2005-01-13
US8715690B2 (en) 2014-05-06
US20060083756A1 (en) 2006-04-20
US9717784B2 (en) 2017-08-01
US20100189733A1 (en) 2010-07-29
US20120034630A1 (en) 2012-02-09
HK1158694A1 (zh) 2015-12-11
DK2000535T3 (da) 2014-04-22
US20100189743A1 (en) 2010-07-29
EP1036180B2 (fr) 2011-11-02
US20100226934A1 (en) 2010-09-09
US20070041990A1 (en) 2007-02-22
WO1999029871A3 (fr) 1999-08-19
PT1992696E (pt) 2014-05-27
ES2317679T3 (es) 2009-04-16
ES2458309T3 (es) 2014-04-30
FR2772047B1 (fr) 2004-04-09
US20050084497A1 (en) 2005-04-21
BE2014C050I2 (da) 2018-07-04
US7297537B2 (en) 2007-11-20
CY1115405T1 (el) 2017-01-04
US20070041989A1 (en) 2007-02-22
US20100221276A1 (en) 2010-09-02
HK1126522A1 (zh) 2014-07-25
US20070253971A1 (en) 2007-11-01
EP1036180B1 (fr) 2008-10-29
PT1036180E (pt) 2009-02-10
CY1115424T1 (xx) 2016-04-13
US7223594B2 (en) 2007-05-29
AT412664T (de) 2008-11-15
US20110135677A1 (en) 2011-06-09
US20150175668A1 (en) 2015-06-25
US20090123490A1 (en) 2009-05-14
US20090162918A1 (en) 2009-06-25
EP2316925B1 (fr) 2015-07-08
US20070048780A1 (en) 2007-03-01
PT2000535E (pt) 2014-05-02
HK1125676A1 (zh) 2014-07-25
BE2014C049I2 (da) 2018-07-04
US8916353B2 (en) 2014-12-23
US7604808B2 (en) 2009-10-20
US7179472B2 (en) 2007-02-20
US20100209453A1 (en) 2010-08-19
US6703023B1 (en) 2004-03-09
US20100203072A1 (en) 2010-08-12
US20100189735A1 (en) 2010-07-29
EP3002331A1 (fr) 2016-04-06
US7407803B2 (en) 2008-08-05
US20070065925A1 (en) 2007-03-22
US7740866B2 (en) 2010-06-22
US20150182616A1 (en) 2015-07-02
EP2330188B1 (fr) 2015-07-15
US20100074919A1 (en) 2010-03-25
US7741026B2 (en) 2010-06-22
US8124723B2 (en) 2012-02-28
US7425444B2 (en) 2008-09-16
US20090092627A1 (en) 2009-04-09
US20100166791A1 (en) 2010-07-01
CY1116761T1 (el) 2017-03-15
WO1999029871A2 (fr) 1999-06-17
US7148015B2 (en) 2006-12-12
US20040076635A1 (en) 2004-04-22
US20100189734A1 (en) 2010-07-29
EP1992696B1 (fr) 2014-02-19
US20060222663A1 (en) 2006-10-05
US20120005768A1 (en) 2012-01-05
DE69840174D1 (de) 2008-12-11
US20040091502A1 (en) 2004-05-13
US10052375B2 (en) 2018-08-21
US20100221283A1 (en) 2010-09-02
EP2000535A1 (fr) 2008-12-10
US7244433B2 (en) 2007-07-17
US7722883B2 (en) 2010-05-25
HK1158254A1 (zh) 2016-03-18
ES2548145T3 (es) 2015-10-14
HK1222415A1 (zh) 2017-06-30
FR2772047A1 (fr) 1999-06-11
US20070110767A1 (en) 2007-05-17
AU1491699A (en) 1999-06-28
PT2330188E (pt) 2015-10-23
US7758865B2 (en) 2010-07-20
PT2316925E (pt) 2015-10-23
US7405075B2 (en) 2008-07-29
US7261898B2 (en) 2007-08-28
DK1036180T4 (da) 2012-01-23
ES2548146T3 (es) 2015-10-14
US20180000927A1 (en) 2018-01-04
US20110033489A1 (en) 2011-02-10
LU92523I2 (fr) 2014-10-20
US7323330B2 (en) 2008-01-29
ES2456959T3 (es) 2014-04-24
US20040265848A1 (en) 2004-12-30
ES2317679T5 (es) 2012-02-24
EP2316925A1 (fr) 2011-05-04
US20100215690A1 (en) 2010-08-26
US8415525B2 (en) 2013-04-09
EP1036180A2 (fr) 2000-09-20
DK2330188T3 (da) 2015-10-19
US20070059324A1 (en) 2007-03-15
US20100172924A1 (en) 2010-07-08
US20080233147A1 (en) 2008-09-25
CY1116837T1 (el) 2017-03-15
EP2000535B1 (fr) 2014-01-22
DK1036180T3 (da) 2009-03-09
US20070059325A1 (en) 2007-03-15
US7390494B2 (en) 2008-06-24
EP2330188A1 (fr) 2011-06-08
US20100189732A1 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
DE69912677D1 (de) Überwachungsgerät
DE69837975D1 (de) Diagnostisches Abbildungsverfahren
DE69937978D1 (de) Festkörperbildaufnahmevorrichtung
DE69923589D1 (de) Prothesenstruktur
DK1277751T3 (da) 2- og 2,5-substituerede phenylketoenoler
DE69837919D1 (de) Digitale kamera mit mehreren betriebsarten
DE69941146D1 (de) Optimierte lokalisierung von netzwerkbetriebsmittel
DE69732831D1 (de) Kontrastmittel
DE60040657D1 (de) Farbdrucker mit doppelnetzwerk
DE59712623D1 (de) Lichtabtastvorrichtung
DE69535520D1 (de) Abgeänderter, verbesserter BRSV Lebend- Impfstoff
DE69826203D1 (de) Drucker
DE69818814D1 (de) Bedienungshandgriff für ein endoskop
DK0900096T3 (da) Manipuleringssikker, tilbagetrækkelig sprøjte
DK1070058T3 (da) (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
DE69812485D1 (de) Geträgerte Phophinimime-Cyclopentadienyl Katalysatoren
DE69907893D1 (de) Vorverzerrer
DE69811882D1 (de) Pumpe mit angelenktem kolben
DE69914412D1 (de) Verfahren zur Erhaltung von Bilddetails bei Kontrastveränderung
DE69926878D1 (de) Optoakustisches bildgebungssystem
DE69930818D1 (de) Neuartige antibiotika
DE69934892D1 (de) Wassermischbare azalidlösung
DE69934419D1 (de) Mischeranordnungen
DE69917850D1 (de) Batterie-Verbindungsplatte
DE69838791D1 (de) Neue exendinagonist verbindungen